1 – 10 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
TARGET-seq: Linking single-cell transcriptomics of human dopaminergic neurons with their target specificity
(2024) In Proceedings of the National Academy of Sciences of the United States of America 121(47). p.1-12
- Contribution to journal › Article
- 2023
-
Mark
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD
- Contribution to journal › Article
-
Mark
Identifying secreted biomarkers of dopaminergic ventral midbrain progenitor cells
- Contribution to journal › Article
- 2022
-
Mark
Single-cell transcriptional and functional analysis of dopaminergic neurons in organoid-like cultures derived from human fetal midbrain
- Contribution to journal › Article
- 2021
-
Mark
Evaluation of TH-Cre knock-in cell lines for detection and specific targeting of stem cell-derived dopaminergic neurons
- Contribution to journal › Article
- 2020
-
Mark
Parkinson’s disease laterality : a 11C-PE2I PET imaging study
(2020) In Journal of Neurology
- Contribution to journal › Article
-
Mark
Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD
(2020) In Proceedings of the National Academy of Sciences of the United States of America 117(26). p.15209-15220
- Contribution to journal › Article
- 2019
-
Mark
Designing stem-cell-based dopamine cell replacement trials for Parkinson’s disease
- Contribution to journal › Article
-
Mark
hESC-Derived Dopaminergic Transplants Integrate into Basal Ganglia Circuitry in a Preclinical Model of Parkinson's Disease
- Contribution to journal › Article
- 2018
-
Mark
Target-specific forebrain projections and appropriate synaptic inputs of hESC-derived dopamine neurons grafted to the midbrain of parkinsonian rats
- Contribution to journal › Article
